Mitchell Warren Authors

Mitchell Warren

Mitchell Warren has been AVAC’s executive director since 2004. He previously led Vaccine Preparedness at IAVI; directed international programs at Female Health Company; and directed PSI in South Africa and Europe. Member of PEPFAR Scientific Advisory Board and International AIDS Society Governing Council and president of the TB Alliance Stakeholder Association.

Latest Articles

Global Health
Global Health
Opinion: The US legacy in HIV is unraveling
29 May 2025
With PEPFAR facing precarious uncertainty, shifting priorities and dwindling expertise raise alarms. Will the U.S. Congress intervene?
Global Health
Global Health
Opinion: The world has a new HIV prevention drug. Let’s use it
19 Dec 2024
There is hope for a new 5 by 3 global target of getting 5 million people on long-acting PrEP to prevent HIV by 2030.
PEPFAR
PEPFAR
Opinion: US leadership matters in fighting AIDS
28 Jun 2021
The failure to appoint a leader for the U.S. President's Emergency Plan for AIDS Relief sends the message that HIV is no longer a priority for the U.S. administration.
COVID-19
COVID-19
Opinion: Why exciting results from vaccine research are just the beginning of efforts to end COVID-19
19 Nov 2020
Decades of research and advocacy that led to achievements in HIV provide important lessons for the global responses to COVID-19.
COVID-19
COVID-19
Opinion: To accelerate search for COVID-19 vaccine, look to HIV and act globally
27 May 2020
Looking back at over 40 years of experience in the HIV response, this op-ed explores what is needed for the containment of a health crisis — and for vaccine success.
HIV/AIDS
HIV/AIDS
Opinion: We won't meet the 2020 AIDS targets. Now what?
3 Dec 2019
It is time to redouble efforts and investments in HIV prevention. In this opinion piece, AVAC Executive Director Mitchell Warren celebrates 2020 as the year of diverse, brave, activist leadership in HIV — from the grassroots to Geneva — and takes a look at its impact.
See all articles by Mitchell Warren